APA   Click to copy
BG, M., P, L., JY, P., G, A., & MB, R. (2023). Sociodemographic disparities in the use of GLP-1 receptor agonists and SGLT-2 inhibitors among US adults with type 2 diabetes: NHANES 2005-March 2020. MedRxiv. https://doi.org/10.1101/2023.03.30.23287965

Chicago/Turabian   Click to copy
BG, Mittman, Le P, Payne JY, Ayers G, and Rothberg MB. “Sociodemographic Disparities in the Use of GLP-1 Receptor Agonists and SGLT-2 Inhibitors among US Adults with Type 2 Diabetes: NHANES 2005-March 2020.” medRxiv (2023).

MLA   Click to copy
BG, Mittman, et al. “Sociodemographic Disparities in the Use of GLP-1 Receptor Agonists and SGLT-2 Inhibitors among US Adults with Type 2 Diabetes: NHANES 2005-March 2020.” MedRxiv, 2023, doi:10.1101/2023.03.30.23287965.

@article{mittman2023a,
  title = {Sociodemographic disparities in the use of GLP-1 receptor agonists and SGLT-2 inhibitors among US adults with type 2 diabetes: NHANES 2005-March 2020},
  year = {2023},
  journal = {medRxiv},
  doi = {10.1101/2023.03.30.23287965},
  author = {BG, Mittman and P, Le and JY, Payne and G, Ayers and MB, Rothberg}
}